Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (118)
Right arrowRequest Permissions
Right arrow Disclaimer
Citing Articles
Right arrowScopus Links
Google Scholar
Right arrow Articles by Kooistra, M.
Right arrow Articles by Vos, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kooistra, M.
Right arrow Articles by Vos, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 13, Issue 11 2853-2860, Copyright © 1998 by Oxford University Press


ORIGINAL ARTICLES

Daily home haemodialysis in the Netherlands; effects on metabolic control, heamodynamics, and quality of life

M Kooistra, J Vos, H Koomans and P Vos
Stichting Thuisdialyse Midden-West Nederland (Foundation of Home Dialysis Mid-West Netherlands) and Department of Nephrology, University Hospital Utrecht, Utrecht, The Netherlands; Corresponding author at: Stichting Thuisdialyse Midden-West Nederland, Brennerbann 130, 3524 BN Utrecht, Nederland

Background: More frequent dialysis has been claimed to improve clinical outcome and quality of life. Methods: Clinical status was optimized in 13 haemodialysis patients during a run-in period of 2 months with three dialysis sessions a week. Thereafter, daily home haemodialysis (DHHD, 6 sessions per week) was initiated. The total weekly dialysis dose (Kt/V) was kept constant. Results: Weekly Kt/V was 3.2±0.13 (M±SEM) before, and 3.2±0.15 after 6 months of DHHD (NS), time averaged concentration of urea (TACu) was 21.2±1.6 mmol/l and 20.1±0.9 mmol/l (NS). Urea reduction was 0.56±0.05 before DHHD, and 0.41±0.06 during DHHD (P<0.0001). Serum K remained unchanged, but significantly less exchange resins were used (P<0.02). Also, the dose of phosphate-binding agents could be decreased. Values for Na, K, Cl, bicarbonate, Ca, PTH, albumin, and Hb remained unchanged. Iron deficiency developed in some patients. Twenty-four-hour blood pressure monitoring showed a decrease of systolic blood pressure (141.1±17.2 mmHg before, and 130.9±19.2 mmHg during DHHD, P<0.001). Diastolic blood pressure remained constant (82.8±7.2 and 76.9±10.1 mmHg, NS). Mean arterial pressure decreased from 102.2±9.5 to 94.9±1.4 mmHg (P<0.02). Blood pressure decreased mainly in previously hypertensive patients. Mean target weight increased 0.8 kg. The amount of antihypertensive drugs used decreased from 1.88±0.35 to 0.75±0.17 (P<0.005, n=7). Dialysis sessions were much more stable, also in patients with cardiac insufficiency. Quality of life questionnaires (Rand 36, Nottingham Health Profile, Uraemic Symptoms Profile) showed a significant improvement of physical condition and fewer uraemic symptoms. Conclusion: DHHD compared to conventional thrice-weekly haemodialysis with similar weekly Kt/V results in an improved haemodynamic control and quality of life, but has lesser impact on metabolic regulation. Key words: daily home haemodialysis; hypertension; quality of life
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CJASNHome page
J. A. Cafazzo, K. Leonard, A. C. Easty, P. G. Rossos, and C. T. Chan
Patient-Perceived Barriers to the Adoption of Nocturnal Home Hemodialysis
Clin. J. Am. Soc. Nephrol., April 1, 2009; 4(4): 784 - 789.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
E. Fong, J. M. Bargman, and C. T. Chan
Cross-Sectional Comparison of Quality of Life and Illness Intrusiveness in Patients Who Are Treated with Nocturnal Home Hemodialysis versus Peritoneal Dialysis
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1195 - 1200.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
P. A. McFarlane, A. Pierratos, A. M. Bayoumi, and D. A. Redelmeier
Estimating Preference Scores in Conventional and Home Nocturnal Hemodialysis Patients
Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 477 - 483.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. F. Vos, O. Zilch, A. Jennekens-Schinkel, M. Salden, J. Nuyen, M. P. Kooistra M, A. C. van Huffelen, and M. M. Sitskoorn
Effect of short daily home haemodialysis on quality of life, cognitive functioning and the electroencephalogram
Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2529 - 2535.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
R. M. Lindsay, P. A. Heidenheim, G. Nesrallah, A. X. Garg, R. Suri, and on behalf of the Daily Hemodialysis Study Group Lo
Minutes to Recovery after a Hemodialysis Session: A Simple Health-Related Quality of Life Question That Is Reliable, Valid, and Sensitive to Change
Clin. J. Am. Soc. Nephrol., September 1, 2006; 1(5): 952 - 959.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Jindal, C. T. Chan, C. Deziel, D. Hirsch, S. D. Soroka, M. Tonelli, and B. F. Culleton
CHAPTER 5: Frequent and Sustained Hemodialysis
J. Am. Soc. Nephrol., March 1, 2006; 17(3_suppl_1): S24 - S27.
[Full Text] [PDF]


Home page
CJASNHome page
R. S. Suri, G. E. Nesrallah, R. Mainra, A. X. Garg, R. M. Lindsay, T. Greene, and J. T. Daugirdas
Daily Hemodialysis: A Systematic Review
Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 33 - 42.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J.-M. Sung, S.-C. Kuo, H.-R. Guo, S.-F. Chuang, S.-Y. Lee, and J.-J. Huang
Decreased Salivary Flow Rate as a Dipsogenic Factor in Hemodialysis Patients: Evidence from an Observational Study and a Pilocarpine Clinical Trial
J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3418 - 3429.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. C. Ayus, M. R. Mizani, S. G. Achinger, R. Thadhani, A. S. Go, and S. Lee
Effects of Short Daily versus Conventional Hemodialysis on Left Ventricular Hypertrophy and Inflammatory Markers: A Prospective, Controlled Study
J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2778 - 2788.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
L. Nanovic
Electrolytes and Fluid Management in Hemodialysis and Peritoneal Dialysis
Nutr Clin Pract, April 1, 2005; 20(2): 192 - 201.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. P. Bots, H. S. Brand, E. C. I. Veerman, J. C. Korevaar, M. Valentijn-Benz, P. D. Bezemer, R. M. Valentijn, P. F. Vos, J. A. Bijlsma, P. M. ter Wee, et al.
Chewing gum and a saliva substitute alleviate thirst and xerostomia in patients on haemodialysis
Nephrol. Dial. Transplant., March 1, 2005; 20(3): 578 - 584.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. P. C. Grooteman and M. J. Nube
Impact of the type of dialyser on the clinical outcome in chronic haemodialysis patients: does it really matter?
Nephrol. Dial. Transplant., December 1, 2004; 19(12): 2965 - 2970.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. P. Kooistra
Frequent prolonged home haemodialysis: three old concepts, one modern solution
Nephrol. Dial. Transplant., January 1, 2003; 18(1): 16 - 18.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
Z. J. Twardowski
PHD(R): the technological solution for daily haemodialysis?
Nephrol. Dial. Transplant., January 1, 2003; 18(1): 19 - 23.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Floridi, F. Antolini, F. Galli, R. M. Fagugli, E. Floridi, and U. Buoncristiani
Daily haemodialysis improves indices of protein glycation
Nephrol. Dial. Transplant., May 1, 2002; 17(5): 871 - 878.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. B. Drueke
Foreword: Extraskeletal calcifications in patients with chronic renal failure
Nephrol. Dial. Transplant., February 1, 2002; 17(2): 330 - 331.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
Z. J. Twardowski
Daily dialysis: is this a reasonable option for the new millennium?
Nephrol. Dial. Transplant., July 1, 2001; 16(7): 1321 - 1324.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Schomig, A. Eisenhardt, and E. Ritz
Controversy on optimal blood pressure on haemodialysis: normotensive blood pressure values are essential for survival
Nephrol. Dial. Transplant., March 1, 2001; 16(3): 469 - 474.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
I. Ledebo, N. Lameire, B. Charra, F. Locatelli, M. Kooistra, M. Kessler, and C. Jacobs
Improving the outcome of dialysis--opinion vs scientific evidence
Nephrol. Dial. Transplant., September 1, 2000; 15(9): 1310 - 1316.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. Ring, M. P. Merkus, and R. T. Krediet
Physical symptoms and quality of life in patients on chronic dialysis: results of The Netherlands Cooperative Study on Adequacy of dialysis (NECOSAD)
Nephrol. Dial. Transplant., February 1, 2000; 15(2): 280 - 281.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Pierratos
Nocturnal home haemodialysis: an update on a 5-year experience
Nephrol. Dial. Transplant., December 1, 1999; 14(12): 2835 - 2840.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.